Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.3546
+0.0188 (5.60%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Mersana Therapeutics Employees
Mersana Therapeutics had 102 employees as of December 31, 2024. The number of employees decreased by 21 or -17.07% compared to the previous year.
Employees
102
Change (1Y)
-21
Growth (1Y)
-17.07%
Revenue / Employee
$397,029
Profits / Employee
-$678,353
Market Cap
44.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
MRSN News
- 14 days ago - Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress - GlobeNewsWire
- 6 weeks ago - Mersana Therapeutics, Inc. (MRSN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Mersana Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025 - GlobeNewsWire
- 2 months ago - Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 3 months ago - Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday? - Benzinga